Steven Nurkin, MD, MS, FACS

Associate Professor of Oncology
Department of Surgical Oncology

Steven Nurkin, MD, MS, FACS

Dr. Nurkin is a fellowship trained surgical oncologist who specializes in gastrointestinal pre-cancerous conditions and cancers of the entire GI tract, with a focus in colon, appendix, rectum and anus.

His expertise is in minimally invasive approaches to tumors with advanced endoscopic, laparoscopic and robotic techniques. Advanced endoscopic procedures include: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection and Transanal Minimally Invasive and Endoscopic Microsurgery (Tamis/TEM).

His clinical research interests focus on improving the outcomes and quality of care in patients with cancer. He is a Quality Leader at Roswell Park, as chair of the OR Quality committee, a member of the hospital QI executive committee and surgeon champion of NSQIP. He also spearheaded the implementation of Enhance Recovery After Surgery (ERAS) at Roswell Park.

Dr. Nurkin is a panel member for the National Comprehensive Cancer Network (NCCN), in Colon, Rectal and Anal cancers and helps develop national guidelines for the management of these diseases. Dr. Nurkin is a member of the American College of Surgeons (ACS), Society of Surgical Oncology, (as well as a member of the Colorectal Disease Site Work Group for the SSO), the American Society of Clinical Oncology (ASCO) and American Society of Colon and Rectal Surgeons (ASCRS).


Related Videos

Nonoperative Management After Neoadjuvant Therapy for Rectal Cancer: A Single Institution Experience Over 5 Years Video

Nonoperative Management After Neoadjuvant Therapy for Rectal Cancer: A Single Institution Experience Over 5 Years

Steven Nurkin, MD, MS, FACS, discusses nonoperative management after neoadjuvant therapy for rectal cancer. This lecture looks at a single institution's experience over five years.

Robotic Pelvic Exenteration for Locally Advanced Prostate Cancer Video

Robotic Pelvic Exenteration for Locally Advanced Prostate Cancer

Steven Nurkin, MD, presents on a case of a 47-year-old male who has locally advanced prostate cancer.